List of works - Nora M Chapman

5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart

scientific article published on April 2008

5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.

scientific article

A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome

scientific article published on 01 December 1995

An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses

scientific article published on 01 January 1994

Animal model of alcoholic pancreatitis: role of viral infections

scientific article published on November 2003

Caspase-3 activation and ERK phosphorylation during CVB3 infection of cells: influence of the coxsackievirus and adenovirus receptor and engineered variants

scientific article published on April 2003

Comoviruses and enteroviruses share a T cell epitope.

scientific article published on January 1992

Complete Genome Sequence of the Circular Extrachromosomal Element of Naegleria gruberi Strain EGB Ribosomal DNA.

scientific article published on 8 February 2018

Corrigendum: Three capsid amino acids notably influence coxsackie B3 virus stability

scientific article published on January 2017

Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice

scientific article published on 01 January 1992

Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-α-reactive CD4 T cells in A/J mice.

scientific article published on 14 July 2012

Coxsackievirus B3: Primary structure of the 5′ non-coding and capsid protein-coding regions of the genome

scientific article published on 01 October 1985

Coxsackievirus Genetics and the Cardiovirulent Viral Phenotype

article

Coxsackievirus can persist in murine pancreas by deletion of 5' terminal genomic sequences

scientific article published on 11 August 2014

Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice.

scientific article

Detection of cardiac myosin heavy chain-α-specific CD4 cells by using MHC class II/IAk tetramers in A/J mice

scientific article published on 18 July 2011

Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry? Reply to Hansson SF, Korsgren S, Pontén F et al [letter].

scientific article published on 16 January 2014

Domain I of the 5' non-translated genomic region in coxsackievirus B3 RNA is not required for productive replication.

scientific article published on 8 June 2016

Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells

scientific article published on November 2007

Enterovirus

Enteroviruses

Enteroviruses and type 1 diabetes

scientific article published in November 2011

Enteroviruses in the Mouse Model of Type 1 Diabetes

Enterovirus‡

Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS.

scientific article published in May 1988

Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas.

scientific article published on 5 November 2013

Expression of an antigenic adenovirus epitope in a group B coxsackievirus

scientific article published on May 2000

Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3m) and comparison to other infectious CVB3 cDNAs

scientific article published on 01 August 1997

Genetic determinants of virulence in the group B coxsackieviruses

Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.

scientific article

Genomic regions of coxsackievirus B3 associated with cardiovirulence

scholarly article by Cheol Lee et al published July 1997 in Journal of Medical Virology

Genomic regions of coxsackievirus B3 associated with cardiovirulence

scientific article published on 01 July 1997

Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency

scientific article

Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis.

scientific article published on June 1990

Molecular cloning and partial characterization of the coxsackievirus B3 genome

scientific article published on 01 January 1985

Monoclonal antibody against mouse CAR following genetic immunization

scientific article published on February 2004

Mucin-1 is required for Coxsackie Virus B3-induced inflammation in pancreatitis

scientific article published on 23 July 2019

Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.

scientific article

Mutations in a conserved enteroviral RNA oligonucleotide sequence affect positive strand viral RNA synthesis.

scientific article

National Institutes of Health-Sponsored Workshop on Inflammation and Immunity in Dilated Cardiomyopathy

article

Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy

scientific article published on January 2008

Prior immune exposure can protect or can enhance pathology in the enteroviruses: what predicts the outcome?

scientific article published on 9 December 2016

Progress toward vaccines against viruses that cause heart disease.

scientific article published in May 2000

Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions

scientific article

Reversion to wildtype of a mutated and nonfunctional coxsackievirus B3CRE(2C).

scientific article published on 26 April 2016

Sequence specificity for uridylylation of the viral peptide linked to the genome (VPg) of enteroviruses

scientific article published on 11 June 2015

Sites other than nucleotide 234 determine cardiovirulence in natural isolates of coxsackievirus B3

scientific article published on 01 July 1997

The Coxsackie B Viruses

The Primary Viruses of Myocarditis

The diagnosis of insulitis in human type 1 diabetes.

scientific article

The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model

scientific article published on 30 April 2003

Three capsid amino acids notably influence coxsackie B3 virus stability

scientific article published on 20 October 2015

Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

scientific article

Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment

scientific article

List of works by Nora M Chapman

5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart

5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.

A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome

An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses

Animal model of alcoholic pancreatitis: role of viral infections

Caspase-3 activation and ERK phosphorylation during CVB3 infection of cells: influence of the coxsackievirus and adenovirus receptor and engineered variants

Comoviruses and enteroviruses share a T cell epitope.

Complete Genome Sequence of the Circular Extrachromosomal Element of Naegleria gruberi Strain EGB Ribosomal DNA.

Corrigendum: Three capsid amino acids notably influence coxsackie B3 virus stability

Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice

Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-α-reactive CD4 T cells in A/J mice.

Coxsackievirus B3: Primary structure of the 5′ non-coding and capsid protein-coding regions of the genome

Coxsackievirus Genetics and the Cardiovirulent Viral Phenotype

Coxsackievirus can persist in murine pancreas by deletion of 5' terminal genomic sequences

Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice.

Detection of cardiac myosin heavy chain-α-specific CD4 cells by using MHC class II/IAk tetramers in A/J mice

Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry? Reply to Hansson SF, Korsgren S, Pontén F et al [letter].

Domain I of the 5' non-translated genomic region in coxsackievirus B3 RNA is not required for productive replication.

Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells

Enterovirus

Enteroviruses

Enteroviruses

Enteroviruses and type 1 diabetes

Enteroviruses in the Mouse Model of Type 1 Diabetes

Enterovirus‡

Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS.

Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas.

Expression of an antigenic adenovirus epitope in a group B coxsackievirus

Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3m) and comparison to other infectious CVB3 cDNAs

Genetic determinants of virulence in the group B coxsackieviruses

Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.

Genomic regions of coxsackievirus B3 associated with cardiovirulence

Genomic regions of coxsackievirus B3 associated with cardiovirulence

Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency

Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis.

Molecular cloning and partial characterization of the coxsackievirus B3 genome

Monoclonal antibody against mouse CAR following genetic immunization

Mucin-1 is required for Coxsackie Virus B3-induced inflammation in pancreatitis

Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.

Mutations in a conserved enteroviral RNA oligonucleotide sequence affect positive strand viral RNA synthesis.

National Institutes of Health-Sponsored Workshop on Inflammation and Immunity in Dilated Cardiomyopathy

Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy

Prior immune exposure can protect or can enhance pathology in the enteroviruses: what predicts the outcome?

Progress toward vaccines against viruses that cause heart disease.

Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions

Reversion to wildtype of a mutated and nonfunctional coxsackievirus B3CRE(2C).

Sequence specificity for uridylylation of the viral peptide linked to the genome (VPg) of enteroviruses

Sites other than nucleotide 234 determine cardiovirulence in natural isolates of coxsackievirus B3

The Coxsackie B Viruses

The Primary Viruses of Myocarditis

The diagnosis of insulitis in human type 1 diabetes.

The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model

Three capsid amino acids notably influence coxsackie B3 virus stability

Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment